secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeneDx Holdings Corp. (WGS)
CIK:        0001818331
Form:       8-K
Filed at:   2023-05-22T23:59:59+00:00
Accession:  0001818331-23-000046
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GeneDx regains Nasdaq minimum bid price compliance after reverse stock split
----------------------------------------------------------------------------

- Nasdaq notified GeneDx on May 18, 2023 that it met $1.00 minimum bid for 10 consecutive days.
- Company had previously received deficiency notice on Dec 28, 2022 for bid price below $1.00.
- Compliance achieved after 1-for-33 reverse stock split effective May 4, 2023.
- Nasdaq confirmed the matter is closed and listing continues on the Global Select Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818331/000181833123000046/0001818331-23-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818331/000181833123000046/smfr-20230518.htm
  HTML page:      https://secwatch.observer/filing/0001818331-23-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer